Epigenetic Reprogramming in Cancer: The Emerging Role of NSAIDs as Therapeutic Modulators.

Kumari P, Kumari K, Pandey R, Awasthi M, Dang S

Open source

DOI
10.2174/0113894501456716260716051627
Published
2026 Aug 6
Container
Current drug targets
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113894501456716260716051627,
  title = {Epigenetic Reprogramming in Cancer: The Emerging Role of NSAIDs as Therapeutic Modulators.},
  author = {Kumari P and Kumari K and Pandey R and Awasthi M and Dang S},
  year = {2026},
  journal = {Current drug targets},
  doi = {10.2174/0113894501456716260716051627},
  url = {https://doi.org/10.2174/0113894501456716260716051627}
}

RIS

TY  - JOUR
TI  - Epigenetic Reprogramming in Cancer: The Emerging Role of NSAIDs as Therapeutic Modulators.
AU  - Kumari P
AU  - Kumari K
AU  - Pandey R
AU  - Awasthi M
AU  - Dang S
PY  - 2026
JO  - Current drug targets
DO  - 10.2174/0113894501456716260716051627
UR  - https://doi.org/10.2174/0113894501456716260716051627
ER  - 

APA

P, K., K, K., R, P., M, A., & S, D. (2026). Epigenetic Reprogramming in Cancer: The Emerging Role of NSAIDs as Therapeutic Modulators.. Current drug targets. https://doi.org/10.2174/0113894501456716260716051627

Source records